Clearstead Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.01M | Buy |
38,758
+833
| +2% | +$74.4K | 0.04% | 270 |
|
|
2026
Q1 | $2.72M | Buy |
37,925
+2,319
| +7% | +$179K | 0.02% | 312 |
|
|
2025
Q4 | $2.83M | Sell |
35,606
-874
| -2% | -$68.9K | 0.04% | 276 |
|
|
2025
Q3 | $2.75M | Buy |
36,480
+18,538
| +103% | +$1.27M | 0.04% | 273 |
|
|
2025
Q2 | $1.24M | Buy |
17,942
+1,437
| +9% | +$94.2K | 0.02% | 396 |
|
|
2025
Q1 | $1.12M | Buy |
16,505
+3,950
| +31% | +$236K | 0.02% | 387 |
|
|
2024
Q4 | $564K | Sell |
12,555
-32,632
| -72% | -$1.83M | 0.01% | 544 |
|
|
2024
Q3 | $2.84M | Sell |
45,187
-270
| -0.6% | -$15.8K | 0.04% | 251 |
|
|
2024
Q2 | $2.68M | Buy |
45,457
+19,452
| +75% | +$1.22M | 0.05% | 242 |
|
|
2024
Q1 | $1.47M | Buy |
26,005
+1,241
| +5% | +$94.8K | 0.07% | 181 |
|
|
2023
Q4 | $1.96M | Sell |
24,764
-17,161
| -41% | -$1.22M | 0.1% | 154 |
|
|
2023
Q3 | $2.93M | Buy |
41,925
+22,542
| +116% | +$1.6M | 0.08% | 166 |
|
|
2023
Q2 | $1.34M | Buy |
19,383
+2,773
| +17% | +$197K | 0.08% | 174 |
|
|
2023
Q1 | $1.23M | Sell |
16,610
-5,565
| -25% | -$467K | 0.09% | 161 |
|
|
2022
Q4 | $2.07M | Buy |
22,175
+1,206
| +6% | +$116K | 0.16% | 118 |
|
|
2022
Q3 | $2M | Sell |
20,969
-163
| -0.8% | -$16.1K | 0.18% | 107 |
|
|
2022
Q2 | $1.96M | Buy |
21,132
+5,815
| +38% | +$568K | 0.15% | 119 |
|
|
2022
Q1 | $1.55M | Buy |
15,317
+2,600
| +20% | +$273K | 0.11% | 148 |
|
|
2021
Q4 | $1.31M | Buy |
12,717
+1,121
| +10% | +$104K | 0.09% | 157 |
|
|
2021
Q3 | $984K | Sell |
11,596
-308
| -3% | -$25.8K | 0.07% | 177 |
|
|
2021
Q2 | $993K | Buy |
11,904
+581
| +5% | +$47.6K | 0.08% | 168 |
|
|
2021
Q1 | $852K | Buy |
11,323
+393
| +4% | +$28.6K | 0.07% | 171 |
|
|
2020
Q4 | $746K | Sell |
10,930
-502
| -4% | -$32.7K | 0.07% | 174 |
|
|
2020
Q3 | $668K | Sell |
11,432
-912
| -7% | -$56.7K | 0.07% | 160 |
|
|
2020
Q2 | $802K | Buy |
12,344
+1,725
| +16% | +$109K | 0.09% | 148 |
|
|
2020
Q1 | $630K | Sell |
10,619
-2,437
| -19% | -$163K | 0.09% | 143 |
|
|
2019
Q4 | $970K | Buy |
13,056
+321
| +3% | +$22.5K | 0.12% | 129 |
|
|
2019
Q3 | $803K | Sell |
12,735
-246
| -2% | -$14.6K | 0.11% | 131 |
|
|
2019
Q2 | $707K | Sell |
12,981
-2,347
| -15% | -$126K | 0.09% | 139 |
|
|
2019
Q1 | $827K | Sell |
15,328
-892
| -5% | -$55.1K | 0.11% | 121 |
|
|
2018
Q4 | $1.06M | Buy |
16,220
+3,134
| +24% | +$234K | 0.17% | 103 |
|
|
2018
Q3 | $1.03M | Sell |
13,086
-122
| -0.9% | -$8.72K | 0.14% | 111 |
|
|
2018
Q2 | $850K | Sell |
13,208
-778
| -6% | -$51.3K | 0.12% | 113 |
|
|
2018
Q1 | $870K | Buy |
13,986
+1,557
| +13% | +$112K | 0.13% | 116 |
|
|
2017
Q4 | $901K | Sell |
12,429
-6,229
| -33% | -$453K | 0.12% | 111 |
|
|
2017
Q3 | $1.52M | Sell |
18,658
-1,388
| -7% | -$110K | 0.2% | 90 |
|
|
2017
Q2 | $1.61M | Buy |
20,046
+1,375
| +7% | +$109K | 0.24% | 79 |
|
|
2017
Q1 | $1.47M | Buy |
18,671
+619
| +3% | +$49.4K | 0.21% | 83 |
|
|
2016
Q4 | $1.42M | Buy |
+18,052
| New | +$1.46M | 0.23% | 76 |
|
Other funds holding CVS
Clearstead Advisors's CVS Position: Q2 2026 in Review
Clearstead Advisors increased its CVS Health (CVS) stake by 2.2% in Q2 2026, buying an estimated $74.4K and bringing the position to 38,758 shares worth $4.01M. The position accounts for 0.04% of the portfolio, ranked #270.
Clearstead Advisors first reported a position in CVS in Q4 2016 and has held it in 39 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Clearstead Advisors held 38,758 shares of CVS Health worth $4.01M as of Q2 2026.
- Clearstead Advisors bought 833 CVS Health shares in Q2 2026, an estimated $74.4K.
- CVS Health made up 0.04% of Clearstead Advisors's portfolio in Q2 2026, its #270 holding.
- Clearstead Advisors first reported a position in CVS Health in Q4 2016 and has held it in 39 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.